Torrent Pharmaceuticals Limited (TORNTPHARM) — Board Meeting | 29 June 2025(2 announcements)

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Board Meeting 🟡 Notable Neutral 📄 PDF

Torrent Pharmaceuticals announced a multi-step acquisition of J.B. Chemicals & Pharmaceuticals Limited, agreeing to purchase a 46.39% stake from KKR for INR 1,600 per share (totaling INR 11,917 crore), with plans to acquire an additional 2.80% from employees and launch a mandatory open offer for up to 26% of the expanded share capital at INR 1,639.18 per share, while also proposing a merger through a scheme of arrangement to enhance market position and operational synergies.

2 Board Meeting 🟡 Notable Neutral 📄 PDF

Torrent Pharmaceuticals announced a multi-step acquisition of J.B. Chemicals & Pharmaceuticals Limited, agreeing to purchase a 46.39% stake from KKR for INR 1,600 per share (totaling INR 11,917 crore), with a potential 2.80% employee buy-in and a mandatory open offer for up to 26% of the enlarged share capital at INR 1,639.18 per share, while also proposing a scheme of amalgamation that requires regulatory approvals including CCI, SEBI, and stock exchanges, targeting a fully diluted valuation of INR 25,689 crore to expand its product portfolio, market reach, and CDMO capabilities.

About Torrent Pharmaceuticals Limited (TORNTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,49,108.91 Cr P/E: 80.1

View full TORNTPHARM stock details →

📡 Get AI alerts when TORNTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TORNTPHARM — Free

📊 More TORNTPHARM filings

See all TORNTPHARM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TORNTPHARM files new disclosures

Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track TORNTPHARM — Free

Free account · 2 AI queries/day